文献速递慢性肾脏病肾移植血液净化与透析

HIV相关肾病之外:HIV感染者的肾脏疾病进展

Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.
PubMed 文献 · J Am Soc Nephrol · 2017-08-07

在发达国家,抗逆转录病毒治疗使HIV成为慢性病,经典HIV相关肾病已大幅减少,但HIV阳性黑人ESRD风险仍高于白人,可能与APOL1肾风险变异有关。HIV阳性者还面临CKD传统危险因素和抗逆转录病毒药物肾毒性,而HIV阴性者使用TDF暴露前预防也存在肾毒性担忧,肾移植已成为HIV阳性ESRD患者的可行选择。

要点

  • HIV阳性黑人ESRD风险仍高于白人,APOL1肾风险变异是重要原因。
  • HIV阳性者CKD风险包括传统危险因素和抗逆转录病毒药物肾毒性。
  • HIV阴性者使用TDF暴露前预防也需关注肾毒性,肾移植是HIV阳性ESRD患者可行选择。

核心结论

  • HIV感染者CKD仍是重要共病,HIV阴性者接受暴露前预防也需关注肾脏风险。
  • HIV阳性黑人ESRD风险高于白人,可能与APOL1肾风险变异有关。
  • 随着HIV感染者寿命延长,肾移植已成为进展至ESRD者的可行选择。

研究设计与样本

  • 综述,围绕HIV感染背景下APOL1肾风险变异、抗逆转录病毒治疗相关肾毒性及肾移植进展进行总结。

主要发现

  • 在发达国家,经典HIV相关肾病在非洲裔个体中已大幅减少。
  • HIV阳性黑人ESRD发生率仍远高于HIV阳性白人,可能归因于APOL1肾风险变异。
  • HIV阳性者面临CKD传统危险因素和抗逆转录病毒治疗肾毒性等不良后果。
  • HIV阴性者使用替诺福韦二吡呋酯为基础暴露前预防也存在肾毒性担忧。

临床怎么用

  • 对HIV感染者应关注CKD传统危险因素和抗逆转录病毒药物肾毒性。
  • 对HIV阴性者使用TDF暴露前预防时应关注肾脏不良反应。
  • HIV阳性ESRD患者可考虑肾移植作为可行治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In developed countries, remarkable advances in antiretroviral therapy have transformed HIV infection into a chronic condition. As a result, HIV-associated nephropathy, the classic HIV-driven kidney lesion among individuals of African descent, has largely disappeared in these regions. However, HIV-positive blacks continue to have much higher rates of ESRD than HIV-positive whites, which could be attributed to the APOL1 renal risk variants. Additionally, HIV-positive individuals face adverse consequences beyond HIV itself, including traditional risk factors for CKD and nephrotoxic effects of antiretroviral therapy. Concerns for nephrotoxicity also extend to HIV-negative individuals using tenofovir disoproxil fumarate-based pre-exposure prophylaxis for the prevention of HIV infection. Therefore, CKD remains an important comorbid condition in the HIV-positive population and an emerging concern among HIV-negative persons receiving pre-exposure prophylaxis. With the improved longevity of HIV-positive individuals, a kidney transplant has become a viable option for many who have progressed to ESRD. Herein, we review the growing knowledge regarding the APOL1 renal risk variants in the context of HIV infection, antiretroviral therapy-related nephrotoxicity, and developments in kidney transplantation among HIV-positive individuals.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Jotwani V, Atta MG, Estrella MM, et al. Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy. J Am Soc Nephrol. 2017. PMID: 28784698. doi:10.1681/ASN.2017040468

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。